US CDC vaccine panel postpones vote on RSV therapies
Tweet
Share
E-mail
A sign of the CDC is seen on a podium during the meeting of the members of the Advisory Committee on Immunization Practices, as the U.S. Centers for Disease Control and Prevention's (CDC) advisory panel for vaccines convenes in Atlanta, Georgia, U.S. June
(Reuters) -The U.S. Centers for Disease Control and Prevention's revamped vaccine advisory panel on Wednesday postponed its vote on the use of respiratory syncytial virus therapies to Thursday.
The panel, which has convened for a closely watched two-day meeting, was discussing the use of AstraZeneca and Sanofi's Beyfortus and Merck's Enflonsia.
(Reporting by Christy Santhosh and Bhanvi Satija in Bengaluru; Editing by Maju Samuel)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Panama‑flagged cargo ship sinks off eastern India, coast guard says
- Chinese robot beats Usain Bolt's 100m world record at Beijing games
- Hit by Trump tariffs, Quebec loses appetite for quick separation from Canada
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
